Salt CompositionYou Searched
Viranz 600mg Capsule
Veritaz Healthcare Ltd.
₹1,987.5
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Customers also bought
More About Viranz
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Viranz 600mg Capsule is to be taken empty stomach.
How it works
Viranz 600mg Capsule prevents the multiplication of HIV virus in human cells, thereby stopping the HIV virus from producing new viruses.
Caution: It is important to consult your doctor regarding alcohol consumption while taking Viranz 600mg Capsule .
Seek medical advice from your doctor: Viranz 600mg Capsule is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Doctor consultation is advised.
Safe when prescribed by an expert: Viranz 600mg Capsule is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Not Safe: Viranz 600mg Capsule may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Safe when prescribed by an expert: Viranz 600mg Capsule is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Viranz 600mg Capsule may not be needed in these patients. Doctor consultation is advised.
Caution Advised: Viranz 600mg Capsule should be used with caution in patients with liver disease. Dose adjustment of Viranz 600mg Capsule may be needed. Doctor consultation is advised. Use of Viranz 600mg Capsule is not recommended in patients with moderate and severe liver disease.
Manufacturer Address
Titanium Building, 3rd Floor, Hi-tech City, Hyderabad ‚ 500084
References
Flexner C. Antiretroviral Agents and Treatment of HIV Infection. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. New York, New York: McGraw-Hill Medical; 2011. pp. 1643-644
Safrin S. Antiviral Agents. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 861-62
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 455-56
Efavirenz. Uxbridge, Middlesex: Bristol-Myers Squibb House; 1999 (31 Mar. 2019)
Efavirenz. South Ruislip, Middlesex: Aurobindo Pharma - Milpharm Ltd.; 2014 (25 Jan. 2019)
Medscape. EFavirenz (31 Mar. 2019)
Efavirenz. Princeton, New Jersey: Bristol-Myers Squibb Company; 1998 (31 Mar. 2019)
Central Drugs Standard Control Organisation (CDSCO) (31 Mar. 2019)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
